Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference

Summary by Macau Business
– The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April – Samsung Biologics to offer ADC services and invest in advanced development and manufacturing capabilities to better address clients’ needs INCHEON, South Korea, Jan. 15, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business achievements and 202…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Samsung

Samsung

Gyeonggi-Do

Gyeonggi-Do

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal